Ignite Creation Date:
2024-05-06 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05681949
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-24
First Post:
2022-12-13
Brief Title:
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Evaluation of the Trustworthiness of the Application of Artificial Intelligence and Decision Support Systems for the Creation of Tumor Conference Protocols
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADBoard
Brief Summary:
The goal of this observational study is to compare the recommendations of the artificial intelligence clinical decision support system ADBoard with the recommendations of physicians by tumor conferences in patients with hepatobiliary tumors The main questions it aims to answer are
Can ADBoard achieve a high level of similar recommendations as physicians tumor conferences Can ADBoard consider a more complete set of patient-related data than in physicians tumor conferences Can ADBoard reduce the time between the first time the patient is discussed at the tumor conference and the start of the recommended treatment plan Participants will have their hepatobiliary tumor treatments determined by either tumor conference with ADBoard or tumor conference without ADBoard
Can ADBoard achieve a high level of similar recommendations as physicians tumor conferences Can ADBoard consider a more complete set of patient-related data than in physicians tumor conferences Can ADBoard reduce the time between the first time the patient is discussed at the tumor conference and the start of the recommended treatment plan Participants will have their hepatobiliary tumor treatments determined by either tumor conference with ADBoard or tumor conference without ADBoard
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None